Integrated Filling for the quarter ended 31.12.2024
Integrated Filing (Financial)
Filed with BSE ·
6ix hasn’t read this filing yet.
View original source (BSE India)Vista Pharmaceuticals Ltd. on 6ix
Earlier from Vista Pharmaceuticals
- Results For The Quarter And Nine Months Ended 31.12.2024
- Vista Pharmaceuticals Ltd. Press Release Feb 03 2025
- Board Meeting Intimation for Un Audited Financials Results For The Quarter Ended 31.12.2024
- Vista Pharmaceuticals Ltd. Press Release Jan 20 2025
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Later from Vista Pharmaceuticals
- Board Meeting Intimation for Raising Of Funds By Way Of Issue Of Equity Or Convertible Warrants On Preferential Basis,
- Closure of Trading Window
- Vista Pharmaceuticals Ltd. Press Release Feb 14 2025
- Board Meeting Outcome for Outcome Of Board Meeting Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.
- Vista Pharmaceuticals Ltd. Press Release Feb 19 2025
Follow Vista Pharmaceuticals into a list and get an email when it puts out news.
Follow Vista Pharmaceuticals